I’ve been successfully on Ibrutinib for 5.5 years, but when I saw my haematologist recently she told me that the average effective length of Ibrutinib treatment tends to be around 5 years; but not to worry, as a replacement treatment is available if ever needed.
So my questions are – 1) is the 5 year figure generally correct? 2) what replacement treatment would she likely be referring to?
Thanks.
Written by
BSMI
To view profiles and participate in discussions please or .
Average, or more correctly median time of effectiveness means 50% of patients are still finding ibrutinib an effective treatment. We have early ibrutinib trial participants now moving into their second decade of successful management of their CLL with ibrutinib. Offhand I don't have the stats, which differ for those whose first treatment was with ibrutinib and those who have had previous treatments. Treatment naive have longer control.
What comes next depends on where you live, as that determines what treatments are approved and what trials are available to you. Venetoclax is the usual second line therapy, with venetoclax plus rituximab approved as a fixed term treatment with the aim of achieving uMRD and a long remission.
Thanks for that Neil. I'm feeling OK re: CLL, although I have other problems as well. And blood tests are good, so hopefully Ibrutinib will keep taking care of me for years yet.And fortunately in Australia Ibrutinib (& I think Venetoclax) costs are covered by the PBS.
After 4 1/2 years of Ibrutinib I developed afib and had to stop the treatment. Fortunately my labs were all in normal range except for platelets. My hematologist said he would follow me closely on no treatment and monitor for any changes. Platelets came up to normal and everything stayed normal. So if your labs are looking good and lymph nodes are behaving themselves you may want to ask your doctor about your options.
I've heard that too. I've been on Imbruvica for a little over 6 years and every visit I keep wondering if he'll say my blood work is bad and we'll have to change treatment. I wouldn't know what is best for me or work as well with so little side effects as Imbruvica did. Guess I'll wait and see as time passes.
Thank you, that's exactly where I'm up to as well. Just hoping Imbruvica keeps working, but happy to know there are alternatives for us if necessary. Stay well.
Hi BSMI, Just want to say I am now in my 9th year on Ibrutinib and it has worked well for me following on from conventional chemotherapy, FCR and BR. My only problem is erratic blood pressure and am now awaiting a decision regarding changing the treatment.I must admit to the many side affects that I have had suffered, but I do have other medical issues and the clinician’s are still unsure of what is responsible for my ongoing problems. I wish you well.
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.
Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.